Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer

Gynecologic Oncology

Volumn 102, Issue 3, 2006, Pages 493-499

  Kawase, Setsuko ^a,b   Okuda, Takahito ^a,c   Ikeda, Mitsuru ^d   Ishihara, Shunichi ^b   Itoh, Yoshiyuki ^a   Yanagawa, Shigeo ^a   Ishigaki, Takeo ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^c Kohseiren Showa Hospital   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Concurrent chemoradiation therapy; Intraarterial chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; RADIATION RESPONSE; RECTUM; RECTUM PERFORATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT DURATION; TUMOR VOLUME; UNIVARIATE ANALYSIS; UTERINE ARTERY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33748467087     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.009     Document Type: Article

References (36)

1. Hamberger A.D., Fletcher G.H., and Wharton J.T. Results of treatment of early stage I carcinoma of the uterine cervix with intracavitary radium alone. Cancer 41 3 (1978) 980-985
2. Perez C.A., Camel H.M., Kao M.S., and Hederman M.A. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report. Gynecol. Oncol. 27 2 (1987) 129-140
3. Fyles A.W., Pintilie M., Kirkbride P., Levin W., Manchul L.A., and Rawlings G.A. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother. Oncol. 35 2 (1995) 107-117
4. van Nagell Jr. J.R., Rayburn W., Donaldson E.S., et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 44 6 (1979) 2354-2361
5. Piver M.S., Marchetti D.L., Patton T., Halpern J., Blumenson L., and Driscoll D.L. Radical hysterectomy and pelvic lymphadenectomy versus radiation therapy for small (less than or equal to 3 cm) stage IB cervical carcinoma. Am. J. Clin. Oncol. 11 1 (1988) 21-24
6. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 42 3 (1998) 531-540
7. Ramzy I., Yuzpe A.A., and Hendelman J. Adenoid cystic carcinoma of uterine cervix. Obstet. Gynecol. 45 6 (1975) 679-683
8. Reagan J.W., and Fu Y.S. Histologic types and prognosis of cancers of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 5 7 (1979) 1015-1020
9. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 9077 (1997) 535-540
10. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 5 (1999) 1339-1348
11. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 15 (1999) 1144-1153
12. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 15 (1999) 1154-1161
13. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 8 (2000) 1606-1613
14. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340 15 (1999) 1137-1143
15. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 9284 (2001) 781-786
16. Kirwan J.M., Symonds P., Green J.A., Tierney J., Collingwood M., and Williams C.J. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother. Oncol. 68 3 (2003) 217-226
17. Sueyama H., Nakano M., Sakumoto K., et al. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer. Gynecol. Oncol. 59 3 (1995) 327-332
18. Yamakawa Y., Fujimura M., Hidaka T., Hori S., and Saito S. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Gynecol. Oncol. 77 2 (2000) 264-270
19. Nagata Y., Araki N., Kimura H., et al. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer. J. Vasc. Interv. Radiol. 11 3 (2000) 313-319
20. Chen H.S., and Gross J.F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep. 64 1 (1980) 31-40
21. Kodaira T., Fuwa N., Kamata M., et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?. Int. J. Radiat. Oncol. Biol. Phys. 52 3 (2002) 627-636
22. Kim S.H., Kim S.C., Choi B.I., and Han M.C. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 190 3 (1994) 807-811
23. Tsuji K., Yamada R., Kawabata M., et al. Effect of balloon occluded arterial infusion of anticancer drugs on prognosis of cervical cancer treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 32 5 (1995) 1337-1345
24. Kokubo M., Tsutsui K., Nagata Y., et al. Radiotherapy combined with transcatheter arterial infusion for locally advanced cervical cancer. Acta Oncol. 37 2 (1998) 143-149
25. Okuda T., Itho Y., Ikeda M., et al. Long-term result of high dose-rate afterloading brachytherapy in cell carcinoma of the cervix: relationship between facility structure outcome. Jpn. J. Clin. Oncol. 34 3 (2004) 142-148
26. Perez C.A., Grigsby P.W., Nene S.M., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69 11 (1992) 2796-2806
27. Eifel P.J., Burke T.W., Morris M., and Smith T.L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol. 59 1 (1995) 38-44
28. Chen R.J., Lin Y.H., Chen C.A., Huang S.C., Chow S.N., and Hsieh C.Y. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol. Oncol. 73 2 (1999) 184-189
29. Kameyama Y., Okazaki N., Nakagawa M., Koshida H., Nakamura M., and Gemba M. Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices. Toxicol. Lett. 52 1 (1990) 15-24
30. Kawai Y., Taniuchi S., Okahara S., Nakamura M., and Gemba M. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biol. Pharm. Bull. 28 8 (2005) 1385-1388
31. Uehara T., Watanabe H., Itoh F., et al. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch. Toxicol. 79 8 (2005) 451-460
32. Goldstein R.S., and Mayor G.H. Minireview. The nephrotoxicity of cisplatin. Life Sci. 32 7 (1983) 685-690
33. Safirstein R., Winston J., Goldstein M., Moel D., Dikman S., and Guttenplan J. Cisplatin nephrotoxicity. Am. J. Kidney Dis. 8 5 (1986) 356-367
34. Meyer K.B., and Madias N.E. Cisplatin nephrotoxicity. Miner. Electrolyte. Metab. 20 4 (1994) 201-213
35. Moore D.H., Blessing J.A., McQuellon R.P., et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J. Clin. Oncol. 22 15 (2004) 3113-3119
36. Kodaira T., Fuwa N., Toita T., et al. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56 3 (2003) 769-777